Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SARNP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
STXBP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
E2F4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSPA9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UIMC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSTA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102725436 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC25A38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMD13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC146880 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDEM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HFE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNRPA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCTN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KPNA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on